<DOC>
	<DOCNO>NCT00361348</DOCNO>
	<brief_summary>The purpose study determine Paliferim interact Heparin .</brief_summary>
	<brief_title>Palifermin DDI ( Drug Drug Interaction )</brief_title>
	<detailed_description>Heparin show modulate bind palifermin KGF receptor . Therefore , part post-marketing regulatory commitment Food Drug Administration ( FDA ) , purpose study characterize potential pharmacokinetic pharmacodynamic drug-drug interaction continuous IV infusion heparin IV bolus injection palifermin . If interaction observe co-administration , expect outcome would modulation clearance palifermin change heparin activity . Although commonly conduct , literature describe heparin drug-drug interaction study conduct healthy subject use subcutaneous ( Grimaudo et al,1988 ; Kroon et al , 1992 ) intravenous ( Caplain al , 1999 ; Noveck &amp; Hubbard , 2004 ; Spowart et al , 1988 ) formulation . Based experience , appropriate investigate heparin drug-drug interaction healthy subject . In study , subject receive single 60 mcg/kg dose palifermin either monotherapy conjunction continuous heparin infusion . The 60 mcg/kg dose palifermin explore study identical current recommend daily dosage patient hematologic malignancy undergo autologous PBPC transplantation receive total body irradiation high-dose chemotherapy : 3 consecutive day administer two cycle 5-day non-dosing interval .</detailed_description>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Inclusion : Baseline aPTT value subject must within normal range . In addition , subject must also test negative occult blood stool , history bleeding disorder use aspirin NSAIDs within 14 day study Day 1 . Exclusion : The study also exclude subject evidence history thrombocytopenia , heparininduced thrombocytopenia contraindication heparin ( e.g. , recent surgery ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Palifermin</keyword>
	<keyword>drug interaction</keyword>
</DOC>